AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 27889320 — intervention group
Group type: EXPERIMENTAL
Intervention: Two intraoperative, intravenous doses (IOIO)
Number of subjects: 75
Study 27889320 — intervention group
Group type: EXPERIMENTAL
Intervention: Two intraoperative local applications (LALA)
Number of subjects: 75
Study 27889320 — intervention group
Group type: EXPERIMENTAL
Intervention: One preoperative plus two intraoperative, intravenous doses (POIOIO)
Number of subjects: 75
Study 26459326 — intervention group
Group type: EXPERIMENTAL
Intervention: Community Health Workers (CHWs) providing maternal and newborn health education through home visits and community engagement.
Number of subjects: 40
Study 26459326 — intervention group
Group type: EXPERIMENTAL
Intervention: Early community engagement and supportive supervision of CHWs.
Number of subjects: 40
Study 23025424 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the dosing aid
Number of subjects: 0
Study 23025424 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the dosing aid with the drop guider
Number of subjects: 0
Study 23025424 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the dosing aid together with patient education
Number of subjects: 0
Study 23025424 — intervention group
Group type: EXPERIMENTAL
Intervention: Use of the dosing aid and drop guider together with patient education
Number of subjects: 0
Study 23025424 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21736730 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention (BI)
Number of subjects: 400
Study 21736730 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention plus Cognitive Behavioral Treatment (CBT)
Number of subjects: 400
Study 21736730 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention plus nutritional supplements of seal oil
Number of subjects: 400
Study 21736730 — intervention group
Group type: EXPERIMENTAL
Intervention: Brief Intervention plus nutritional supplements of soy oil
Number of subjects: 400
Study 21736730 — intervention group
Group type: COMPARATOR
Intervention: Control group (treatment as usual)
Number of subjects: 400
Study 19772447 — intervention group
Group type: EXPERIMENTAL
Intervention: AIR inhaled insulin
Number of subjects: 0
Study 19772447 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous insulin (SC)
Number of subjects: 0
Study 17294445 — intervention group
Group type: EXPERIMENTAL
Intervention: LHT+IT-DC (intratumoral injection of autologous immature dendritic cells after local hyperthermia)
Number of subjects: 18
Study 17294445 — intervention group
Group type: COMPARATOR
Intervention: IT-DC (intratumoral injection of autologous immature dendritic cells without local hyperthermia)
Number of subjects: 18
Study 17294445 — intervention group
Group type: EXPERIMENTAL
Intervention: LHT+IT-DC
Number of subjects: 18
Study 17294445 — intervention group
Group type: COMPARATOR
Intervention: IT-DC
Number of subjects: 18
Study 15266633 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with 860 nm gallium/aluminum/arsenide laser at a dosage of 6 J/cm2, treated three times per week for 5 weeks.
Number of subjects: 15
Study 15266633 — intervention group
Group type: COMPARATOR
Intervention: Sham laser treatment, treated three times per week for 5 weeks.
Number of subjects: 15
Study 15266633 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (LLLT and sham)
Number of subjects: 15
Study 11158191 — intervention group
Group type: EXPERIMENTAL
Intervention: Orchiectomy with flutamide
Number of subjects: 1263
Study 11158191 — intervention group
Group type: COMPARATOR
Intervention: Orchiectomy without flutamide
Number of subjects: 1263
Study 9358196 — intervention group
Group type: EXPERIMENTAL
Intervention: Clarithromycin
Number of subjects: 0
Study 9358196 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8203201 — intervention group
Group type: EXPERIMENTAL
Intervention: Penicillin V (pcV) given intermittently upon signs of upper respiratory tract infections (URTI)
Number of subjects: 76
Study 8203201 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 76
Study 3673877 — intervention group
Group type: EXPERIMENTAL
Intervention: Initial ST segment depression
Number of subjects: 304
Study 3673877 — intervention group
Group type: COMPARATOR
Intervention: Initial ST segment elevation
Number of subjects: 304
Study 29661497 — intervention group
Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy with irinotecan (CPT‐11; 60 mg/m2 intravenously on days 1 and 8) and nedaplatin (NDP; 80 mg/m2 intravenously on day 1), administered within 6 weeks after surgery and repeated every 28 days for up to 5 cycles.
Number of subjects: 62
Study 26655923 — intervention group
Group type: EXPERIMENTAL
Intervention: Shower group
Number of subjects: 444
Study 26655923 — intervention group
Group type: COMPARATOR
Intervention: Nonshower group
Number of subjects: 444
Study 24846652 — intervention group
Group type: EXPERIMENTAL
Intervention: AMG 157 (700 mg)
Number of subjects: 31
Study 24846652 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 31
Study 22119261 — intervention group
Group type: COMPARATOR
Intervention: Closure of the donor site
Number of subjects: 50
Study 22119261 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonclosure of the donor site
Number of subjects: 50
Study 20195023 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical thrust manipulations
Number of subjects: 47
Study 20195023 — intervention group
Group type: COMPARATOR
Intervention: Cervical nonthrust mobilizations
Number of subjects: 47
Study 20183666 — intervention group
Group type: EXPERIMENTAL
Intervention: Service use by depressed adolescents
Number of subjects: 0
Study 20183666 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact with a behavioral health specialist
Number of subjects: 0
Study 20183666 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment-related costs
Number of subjects: 0
Study 15662232 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin C (500 mg/day)
Number of subjects: 69
Study 15662232 — intervention group
Group type: EXPERIMENTAL
Intervention: Grape-seed polyphenols (1000 mg/day)
Number of subjects: 69
Study 15662232 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of vitamin C and grape-seed polyphenols
Number of subjects: 69
Study 15662232 — intervention group
Group type: COMPARATOR
Intervention: Placebo (neither intervention)
Number of subjects: 69
Study 11836279 — intervention group
Group type: EXPERIMENTAL
Intervention: GH administration alone
Number of subjects: 31
Study 11836279 — intervention group
Group type: COMPARATOR
Intervention: RT + placebo
Number of subjects: 31
Study 11836279 — intervention group
Group type: EXPERIMENTAL
Intervention: RT + GH
Number of subjects: 31
Study 11836279 — intervention group
Group type: EXPERIMENTAL
Intervention: GH administration
Number of subjects: 31
Study 10549114 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA) injection
Number of subjects: 0
Study 10549114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 10549114 — intervention group
Group type: COMPARATOR
Intervention: NSAIDs
Number of subjects: 0
Study 10549114 — intervention group
Group type: COMPARATOR
Intervention: Steroids
Number of subjects: 0
Study 10549114 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyaluronic Acid (HA) therapy
Number of subjects: 0
Study 7723158 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy (maintaining hemoglobin values between 100 and 120 g/L)
Number of subjects: 69
Study 7723158 — intervention group
Group type: COMPARATOR
Intervention: Restrictive transfusion strategy (maintaining hemoglobin values between 70 and 90 g/L)
Number of subjects: 69
Study 7723158 — intervention group
Group type: EXPERIMENTAL
Intervention: Liberal transfusion strategy
Number of subjects: 69
Study 7723158 — intervention group
Group type: COMPARATOR
Intervention: Restrictive transfusion strategy
Number of subjects: 69
Study 2023348 — intervention group
Group type: EXPERIMENTAL
Intervention: 3 MIU interferon alfa-2a
Number of subjects: 172
Study 2023348 — intervention group
Group type: EXPERIMENTAL
Intervention: 9 MIU interferon alfa-2a
Number of subjects: 172
Study 2023348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 172
Study 6119940 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.2 mg/kg of diazepam
Number of subjects: 13
Study 6119940 — intervention group
Group type: COMPARATOR
Intervention: 3 X 10(‐1) mg/kg of fentanyl
Number of subjects: 13
Study 30716400 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive Disease Management Program (DMP)
Number of subjects: 412
Study 30716400 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 412
Study 29331473 — intervention group
Group type: EXPERIMENTAL
Intervention: Prednisolone
Number of subjects: 131
Study 29331473 — intervention group
Group type: COMPARATOR
Intervention: Itraconazole
Number of subjects: 131
Study 26802643 — intervention group
Group type: EXPERIMENTAL
Intervention: SQ grass sublingual immunotherapy (SLIT) tablet
Number of subjects: 0
Study 25089277 — intervention group
Group type: EXPERIMENTAL
Intervention: Test meal after exercise
Number of subjects: 12
Study 25089277 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 12
Study 25089277 — intervention group
Group type: COMPARATOR
Intervention: Rest after exercise
Number of subjects: 12
Study 21652583 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose (HD) chemotherapy with PBSCs
Number of subjects: 87
Study 21652583 — intervention group
Group type: COMPARATOR
Intervention: Standard dose (SD) chemotherapy
Number of subjects: 87
Study 18971768 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic induction with analgesic suggestion
Number of subjects: 26
Study 18971768 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypnotic induction without analgesic suggestion
Number of subjects: 26
Study 18971768 — intervention group
Group type: COMPARATOR
Intervention: Education about EMG (EDU)
Number of subjects: 26
Study 18971768 — intervention group
Group type: EXPERIMENTAL
Intervention: Merged hypnosis groups (hypnotic induction with and without analgesic suggestion)
Number of subjects: 26
Study 17149527 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored brief advice on alcohol problems
Number of subjects: 2562
Study 16598110 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 2116
Study 16598110 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2116
Study 14641849 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradomestic residual spraying of lambda‐cyhalothrin, E.C., 25 mg/m2
Number of subjects: 2
Study 14641849 — intervention group
Group type: EXPERIMENTAL
Intervention: Spatial fogging of fenitrothion around the houses at 30 g/ha
Number of subjects: 2
Study 14641849 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradomestic residual spraying of lambda‐cyhalothrin three times a year, at a dose slightly greater than 25 mg/m2
Number of subjects: 2
Study 14641849 — intervention group
Group type: EXPERIMENTAL
Intervention: Wall bioassays
Number of subjects: 2
Study 11200148 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral fluoropyrimidines (UFT plus leucovorin, capecitabine, eniluracil plus oral 5‐FU)
Number of subjects: 0
Study 11200148 — intervention group
Group type: EXPERIMENTAL
Intervention: Irinotecan plus 5‐FU/leucovorin
Number of subjects: 0
Study 11200148 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxaliplatin plus 5‐FU/leucovorin
Number of subjects: 0
Study 11200148 — intervention group
Group type: COMPARATOR
Intervention: 5‐FU plus leucovorin
Number of subjects: 0
Study 8975963 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythromycin lactobionate 7 mg per kg
Number of subjects: 22
Study 8975963 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (controls)
Number of subjects: 22
Study 1736348 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide enema (2 mg/100 ml)
Number of subjects: 41
Study 1736348 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 6342163 — intervention group
Group type: EXPERIMENTAL
Intervention: Miconazole nitrate and hydrocortisone (Daktacort)
Number of subjects: 85
Study 6342163 — intervention group
Group type: COMPARATOR
Intervention: Neomycin (Kenacomb)
Number of subjects: 85
Study 6342163 — intervention group
Group type: EXPERIMENTAL
Intervention: Gentamicin-containing steroid ointment
Number of subjects: 85
Study 31358242 — intervention group
Group type: EXPERIMENTAL
Intervention: Pediatric brain tumor survivors
Number of subjects: 157
Study 29679749 — intervention group
Group type: EXPERIMENTAL
Intervention: SC peginterferon beta-1a 125 mcg every two weeks
Number of subjects: 1594
Study 29679749 — intervention group
Group type: COMPARATOR
Intervention: SC interferon beta-1a 44 mcg three times per week
Number of subjects: 1594
Study 26937774 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy drink (Red Bull, 500 ml)
Number of subjects: 18
Study 26937774 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PLA, noncaffeinated, sugar-free)
Number of subjects: 18
Study 24508070 — intervention group
Group type: EXPERIMENTAL
Intervention: Retropubic tension-free vaginal tape (TVT) procedure
Number of subjects: 95
Study 24508070 — intervention group
Group type: EXPERIMENTAL
Intervention: Transobturator tension-free vaginal tape (TVT-O) procedure
Number of subjects: 95
Study 22993936 — intervention group
Group type: EXPERIMENTAL
Intervention: Cycloferon in the complex treatment
Number of subjects: 60
Study 20932189 — intervention group
Group type: EXPERIMENTAL
Intervention: SP6 acupuncture for 5 minutes after obtaining needling sensation (de qi) during menstrual pain (n=32)
Number of subjects: 66
Study 20932189 — intervention group
Group type: COMPARATOR
Intervention: GB39 acupuncture for 5 minutes during menstrual pain (n=34)
Number of subjects: 66
Study 17765564 — intervention group
Group type: EXPERIMENTAL
Intervention: Diluted Sanofi Pasteur smallpox vaccine
Number of subjects: 102
Study 16324343 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 10 mg every night (Group B)
Number of subjects: 131
Study 16324343 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 20 mg every night (Group C)
Number of subjects: 131
Study 16324343 — intervention group
Group type: COMPARATOR
Intervention: Basal treatment (Group A)
Number of subjects: 131
Study 12196338 — intervention group
Group type: EXPERIMENTAL
Intervention: Phenylephrine (PE)
Number of subjects: 20
Study 12196338 — intervention group
Group type: EXPERIMENTAL
Intervention: Isoproterenol (ISO)
Number of subjects: 20
Study 10197569 — intervention group
Group type: EXPERIMENTAL
Intervention: Exclusive breast-feeding (EBF) to 6 months
Number of subjects: 119
Study 10197569 — intervention group
Group type: COMPARATOR
Intervention: Solid foods (SF) twice daily from 4 to 6 months
Number of subjects: 119
Study 10197569 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (EBF and SF)
Number of subjects: 119
Study 7766749 — intervention group
Group type: EXPERIMENTAL
Intervention: Khat leaves (Catha edulis)
Number of subjects: 12
Study 7766749 — intervention group
Group type: COMPARATOR
Intervention: Lettuce
Number of subjects: 12
Study 1967667 — intervention group
Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 mg twice a day
Number of subjects: 272
Study 1967667 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 272
Study 7024154 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastroplasty a.m. Gomez
Number of subjects: 28
Study 7024154 — intervention group
Group type: COMPARATOR
Intervention: Very-low-calorie diet (341 kcal, 1.43 MJ) based on a high-value protein powder
Number of subjects: 28
Study 31786155 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise
Number of subjects: 39
Study 31786155 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbial transplantation from responders
Number of subjects: 39
Study 31786155 — intervention group
Group type: EXPERIMENTAL
Intervention: Machine-learning algorithm integrating baseline microbial signatures
Number of subjects: 39
Study 30343116 — intervention group
Group type: EXPERIMENTAL
Intervention: Ozanimod (intervention in a phase 2 placebo-controlled trial)
Number of subjects: 179
Study 30343116 — intervention group
Group type: EXPERIMENTAL
Intervention: UC-100 score
Number of subjects: 179
Study 29040763 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxytocin (OT)
Number of subjects: 153
Study 29040763 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 153
Study 25808169 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (50 mg)
Number of subjects: 47
Study 25808169 — intervention group
Group type: COMPARATOR
Intervention: Placebo (PBO)
Number of subjects: 47
Study 25808169 — intervention group
Group type: EXPERIMENTAL
Intervention: D-cycloserine (50 mg) and Placebo (PBO)
Number of subjects: 47
Study 22404704 — intervention group
Group type: EXPERIMENTAL
Intervention: Quetiapine (300 or 600 mg/day)
Number of subjects: 584
Study 22404704 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 584
Study 21720429 — intervention group
Group type: EXPERIMENTAL
Intervention: Orlistat 60 mg
Number of subjects: 131
Study 21720429 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 19789295 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadrivalent HPV vaccine
Number of subjects: 18174
Study 19789295 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 18174
Study 18289495 — intervention group
Group type: EXPERIMENTAL
Intervention: IPD (Prevention of Delirium Interventions)
Number of subjects: 60
Study 18289495 — intervention group
Group type: COMPARATOR
Intervention: Traditional care (Control)
Number of subjects: 60
Study 15204466 — intervention group
Group type: EXPERIMENTAL
Intervention: Training Young Old Group (TYOG)
Number of subjects: 42
Study 15204466 — intervention group
Group type: EXPERIMENTAL
Intervention: Training Old Group (TOG)
Number of subjects: 42
Study 15204466 — intervention group
Group type: COMPARATOR
Intervention: Control Young Old Group (CYOG)
Number of subjects: 42
Study 15204466 — intervention group
Group type: COMPARATOR
Intervention: Control Old Group (COG)
Number of subjects: 42
Study 15204466 — intervention group
Group type: EXPERIMENTAL
Intervention: Training (TYOG and TOG)
Number of subjects: 42
Study 11256381 — intervention group
Group type: EXPERIMENTAL
Intervention: Linezolid
Number of subjects: 460
Study 11256381 — intervention group
Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 460
Study 9498448 — intervention group
Group type: EXPERIMENTAL
Intervention: Finlay Institute (Havana) vaccine
Number of subjects: 408
Study 9498448 — intervention group
Group type: EXPERIMENTAL
Intervention: National Institute of Public Health (Oslo) vaccine
Number of subjects: 408
Study 7849954 — intervention group
Group type: EXPERIMENTAL
Intervention: Perflubron emulsion (0.15 to 0.50 mL) administered by subcutaneous injection
Number of subjects: 18
Study 7849954 — intervention group
Group type: EXPERIMENTAL
Intervention: Application of massage to the injection site
Number of subjects: 18
Study 7849954 — intervention group
Group type: EXPERIMENTAL
Intervention: Perflubron emulsion
Number of subjects: 18
Study 3240893 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatment with Ditropan 5 mg t.i.d. for 6 weeks prior to surgery (n = 21)
Number of subjects: 39
Study 3240893 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (n = 18) with no prior treatment for bladder instability
Number of subjects: 39
Study 3240893 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (n = 18)
Number of subjects: 39
Study 30421018 — intervention group
Group type: EXPERIMENTAL
Intervention: Overestimation ratio (overR)
Number of subjects: 258
Study 30421018 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-layered susceptibility vessel sign (TL-SVS)
Number of subjects: 258
Study 28473118 — intervention group
Group type: EXPERIMENTAL
Intervention: Continued thienopyridine plus aspirin therapy for an additional 18 months
Number of subjects: 11648
Study 26040633 — intervention group
Group type: EXPERIMENTAL
Intervention: Engagement in a minimum of 60 min of volunteer activities per week for 6 months
Number of subjects: 400
Study 26040633 — intervention group
Group type: COMPARATOR
Intervention: Maintain existing lifestyle or take on new activities as they see fit
Number of subjects: 400
Study 23447359 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide 14 mg
Number of subjects: 1088
Study 23447359 — intervention group
Group type: EXPERIMENTAL
Intervention: Teriflunomide 7 mg
Number of subjects: 1088
Study 23447359 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1088
Study 21496347 — intervention group
Group type: EXPERIMENTAL
Intervention: Marker Method
Number of subjects: 31
Study 21496347 — intervention group
Group type: EXPERIMENTAL
Intervention: Line of Femur Method
Number of subjects: 31
Study 21496347 — intervention group
Group type: EXPERIMENTAL
Intervention: Both methods
Number of subjects: 31
Study 18048857 — intervention group
Group type: EXPERIMENTAL
Intervention: Intramuscular injections of BoNT‐A (BOTOX 100 U total) and intraarticular injection of normal saline
Number of subjects: 29
Study 18048857 — intervention group
Group type: COMPARATOR
Intervention: Intraarticular injection of TA (40 mg) and intramuscular injection of normal saline
Number of subjects: 29
Study 16863563 — intervention group
Group type: EXPERIMENTAL
Intervention: Traditional Chinese Medicine (TCM) herbal formula containing 11 herbs
Number of subjects: 119
Study 16863563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 119
Study 12641502 — intervention group
Group type: EXPERIMENTAL
Intervention: Triple antibiotic therapy (metronidazole 300 mg, clarithromycin 250 mg, and amoxicillin 500 mg, given four times daily for 2 weeks)
Number of subjects: 140
Study 12641502 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 140
Study 15545314 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen microparticle formulation (3.125 mg, 6.25 mg, 12.5 mg, 25 mg, or 50 mg)
Number of subjects: 98
Study 15545314 — intervention group
Group type: EXPERIMENTAL
Intervention: Flurbiprofen microparticle formulation (12.5 mg and higher doses)
Number of subjects: 98
Study 15545314 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 98
Study 9990623 — intervention group
Group type: EXPERIMENTAL
Intervention: Unipolar configuration
Number of subjects: 25
Study 9990623 — intervention group
Group type: EXPERIMENTAL
Intervention: Lead configuration
Number of subjects: 25
Study 9990623 — intervention group
Group type: EXPERIMENTAL
Intervention: Shock energy (0.1 to 15 J)
Number of subjects: 25
Study 8595479 — intervention group
Group type: EXPERIMENTAL
Intervention: Physostigmine infusion
Number of subjects: 0